Procter & Gamble stock (US7427181091): Q4 revenue meets, EPS beats but volumes dip

Procter & Gamble's Q4 CY2025 revenue hit $22.21B, matching estimates with 1.5% growth, while adjusted EPS of $1.88 topped forecasts. Stock fell 1.9% to $143.31 post-earnings amid volume concerns.

Procter & Gamble released its Q4 CY2025 earnings on May 13, 2026, reporting revenue of $22.21 billion, up 1.5% year-over-year and in line with Wall Street estimates of $22.29 billion, ad-hoc-news.de as of May 13, 2026. Adjusted EPS reached $1.88, beating consensus by 1.2% at $1.86, though organic revenue was flat and sales volumes declined 1%.

The stock traded down 1.9% to $143.31 on NYSE immediately after the report, according to StockStory as of May 13, 2026. Management reiterated full-year adjusted EPS guidance at the $6.96 midpoint, signaling confidence despite adjusted EBITDA missing estimates at $6.39 billion versus $6.46 billion expected.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Procter & Gamble
• Sector/industry: Consumer Staples
• Headquarters/country: United States
• Core markets: North America, Europe, Asia
• Key revenue drivers: Grooming, Health Care, Fabric & Home Care
• Home exchange/listing venue: NYSE (PG)
• Trading currency: USD

Procter & Gamble: core business model

Procter & Gamble operates as a multinational consumer goods company, producing branded products in beauty, grooming, health care, fabric & home care, and baby, feminine & family care segments. Its business model centers on innovation-driven brands like Tide, Pampers, Gillette, and Crest, distributed globally through retail channels. The company invests heavily in R&D to maintain market leadership, with a focus on premium products and sustainability initiatives.

For fiscal year 2025, Procter & Gamble generated the majority of its revenue from North America, followed by Europe and developing markets, according to its latest annual report filed with the SEC.

Main revenue and product drivers for Procter & Gamble

Fabric & Home Care, including Tide and Ariel detergents, remains the largest segment, contributing significantly to overall sales. Grooming products like Gillette razors and Health Care items such as Oral-B also drive growth, bolstered by pricing strategies amid volume pressures. In Q4 CY2025, revenue growth was supported by a 2.5% price increase, offsetting the 1% volume decline, per StockStory as of May 13, 2026.

Industry trends and competitive position

The consumer staples sector faces headwinds from inflation and shifting consumer preferences toward value brands, yet Procter & Gamble's strong brand portfolio provides resilience. Competitors like Unilever and Colgate-Palmolive report similar volume challenges, but PG's 24.2% operating margin in Q4 underscores operational efficiency. Its defensive qualities appeal to US investors seeking stability in portfolios amid economic uncertainty.

Why Procter & Gamble matters for US investors

Listed on NYSE, Procter & Gamble offers US investors exposure to a Dividend King with over 60 years of consecutive increases, generating robust free cash flow of $3.81 billion in Q4 CY2025 (17.1% margin). Its heavy US market reliance—over 40% of sales—ties performance to the domestic economy, making it a staple in retirement portfolios.

Conclusion

Procter & Gamble's Q4 results delivered revenue in line with expectations and an EPS beat, tempered by volume declines and a post-earnings share price drop. Reiterated guidance reflects steady outlook, while its entrenched brands support long-term positioning in consumer staples. Investors track upcoming volume recovery and margin trends amid competitive pressures.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.